The FDA has granted enVVeno Medical investigational device exemption approval to launch a pivotal U.S. study of its enVVe transcatheter venous valve for severe deep chronic venous insufficiency. The ...

April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal Trial Clinical site activation and patient enrollment ...

BD (NYSE:BDX) today announced the commercial launch of its CentroVena One insertion system, a central venous catheter (CVC) ...

Dear Doctors: Can you please address chronic venous insufficiency? My doctor has advised me to use compression socks and elevate the legs. I find the socks hard to put on, and elevating my legs above ...

While complementing Zack Wheeler's return to the mound for the Phillies, Don Mattingly dropped a very interesting Jacob ...

The TAVVE study will begin later this year with ten patients, whose 30-day safety results will be submitted to the FDA.

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and patient enrollment expected to commence later this yearLarge unmet clinical need for approximately 3 ...

Neutrophil extracellular traps (NETs) are increasingly recognized as key mediators in the development of venous thromboembolism (VTE). Animal models and in vitro studies showed that NETs form a ...